Visionix USA announces US launch of VX 610 fundus camera

News
Article

The device features cross-polarized light technology, allowing for image clarity without the need for pupil dilation.

VX 610 fundus camera with retinal images Image credit: Visionix USA

Image credit: Visionix USA

Visionix USA has announced the launch of its VX 610 non-mydriatic automated fundus camera.1 The device features auto alignment, auto focus, and auto capture functions for retinal imaging, according to a news release.

“Our goal is to continuously advance eye care technology, enhance the patient experience, and improve the productivity of eye care professionals,” said Peter Wyles, CEO of Visionix USA, in a statement. “The VX 610 fundus camera demonstrates this commitment with its clear images, compact design, and automated capture features, ensuring precision and efficiency in screening and diagnostics.”

The VX 610 utilizes cross-polarized light technology, which allows for image clarity without the need for pupil dilation.1 Images filters include vascular, choroidal, nerve fibre, and red free, in addition to cup-to-disc ratio for glaucoma screening.2 The device also has a 45-degree field of view and 90-degree mosaic function, with a retinal resolution of 14 microns. In addition to a secured, cloud-based storage ability and automatic database backup, VX 610 also includes a fundus adapter to transfer images to a local PC.2

The device will be featured at Vision Expo West, being held from September 18-21 at the Venetian Expo in Las Vegas, Nevada. At Visionix’s booth #F10065, attendees will be able to experience a live demo of VX 610, in addition to viewing the company’s Optovue OCTs and OCTAs and Briot/Weco lens finishing platforms.1

References:
  1. Visionix unveils the VX 610 automated fundus camera. News release. Visionix USA. August 21, 2024. Accessed August 22, 2024.
  2. Visionix VX 610. Visionix USA. Accessed August 22, 2024. https://www.visionix.com/us/product/vx-610-automated-fundus-camera/
Recent Videos
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
Dr. Julie Rodman discusses retina, imaging, and posterior segment in SECO presentations
Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.
Dr. Julie Rodman previews her SECO presentations
Three EnVision Summit faculty members weigh in on the importance of comanagement in glaucoma management, where artificial intelligence will lead eye care, and what hopes are on the horizon for corneal ectasia treatments.
Yvonne Ou, MD, outlined lifestyle modifications for glaucoma management that have proven beneficial, including yoga and cycling.
© 2025 MJH Life Sciences

All rights reserved.